Response to tubocurarine chloride and its reversal by neostigmine methylsulfate in man
- 19 February 1968
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 203 (8) , 541-544
- https://doi.org/10.1001/jama.203.8.541
Abstract
Thirty patients undergoing surgery were given tubocurarine chloride on a body-weight basis and were monitored electromyographic-ally. Reversal of the neuromuscular blockage was then accomplished with incremental doses of neostigmine methylsulfate. A previous study in which the tubocurarine-induced neuromuscular blockage was reversed with neostigmine administered from 3 to 90 min. after the tubocurarine was reviewed. No precise relationship between a dose of tubocurarine, based on body weight and the final degree of paralysis was observed. The optimum dose of neostigmine required to establish the complete reversal of severe neuromuscular blockade due to tubocurarine is almost 4 to 5 mg. This reversal can be achieved even when the time interval between the relaxant and antidote is only a few min.This publication has 7 references indexed in Scilit:
- Neuromuscular Effects of d-Tubocurarine, Edrophonium and Neostigmine in ManAnesthesiology, 1967
- Blood pH and Plasma Levels of d-TubocurarineAnesthesiology, 1965
- Kinetics of Distribution of Radioactive-Labeled Muscle Relaxants I. Investigations with C14-Dimethyl-d-TubocurarineAnesthesiology, 1964
- Neuromuscular and Electromyographic Studies in ManAnesthesiology, 1964
- Studies in Neuromuscular TransmissionActa Physiologica Scandinavica, 1961
- Studies in Neuromuscular TransmissionActa Physiologica Scandinavica, 1961
- Decamethonium Iodide (C 10): Some Observations on its Action Using ElectromyographyProceedings of the Royal Society of Medicine, 1952